Securities and Exchange Commission v. American Renal Associates Holdings, Inc.

CourtDistrict Court, S.D. New York
DecidedApril 20, 2022
Docket1:21-cv-10366
StatusUnknown

This text of Securities and Exchange Commission v. American Renal Associates Holdings, Inc. (Securities and Exchange Commission v. American Renal Associates Holdings, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Securities and Exchange Commission v. American Renal Associates Holdings, Inc., (S.D.N.Y. 2022).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

SECURITIES AND EXCHANGE COMMISSION, Plaintiff, 21-CV-10366 (JPO)

-v- OPINION AND ORDER

AMERICAN RENAL ASSOCIATE HOLDINGS, et al., Defendants.

J. PAUL OETKEN, District Judge: Plaintiff Securities and Exchange Commission (“SEC”) brings this action against Defendants Jonathan L. Wilcox, Jason M. Boucher, and Karen J. Smith, alleging violations of the Securities Act and the Exchange Act. (Dkt. No. 1.)1 Before the Court is Defendants’ motion to transfer this action to the District of Massachusetts pursuant to 28 U.S.C. § 1404(a). For the following reasons, Defendants’ motion is granted. I. Background A. Factual Allegations2 In December 2021, the SEC’s Washington, DC office filed a complaint alleging that Defendants engaged in a fraudulent revenue recognition scheme intended to make ARA’s financial performance appear better than it actually was. (Compl. ¶ 1.) ARA partners with

1 American Renal Associates Holdings, Inc. (“ARA”) was originally a defendant in this case. However, with ARA’s consent, the Court entered a final judgment against ARA on December 8, 2021. (Dkt. No. 11.) ARA was subsequently terminated from this action. 2 The following facts, drawn from the Complaint (Dkt. No. 1 (“Compl.”)), are presumed true for the purposes of this Opinion and Order. doctors across the United States to operate dialysis clinics as joint ventures. (Compl. ¶ 7.) In these joint ventures, the doctors handle all patient care and ARA handles billings, collections, revenue management, and patient insurance issues. (Id.) During the relevant period, ARA received a large amount of its revenue from insurance reimbursement for dialysis treatments.

(Id.) Because ARA did not know what rate different insurance companies would pay for dialysis treatments, revenue recognition involved two steps: ARA first estimated the revenue it would receive and then updated this estimate after receiving information about the amount ARA was actually paid. (Compl. ¶ 8.) These updates are called “topside adjustments” and ARA’s accounting standards required that ARA base these adjustments on patient-level payment information. (Compl. ¶ 8–9.) However, Defendants allegedly did not do what was required by internal accounting standards. Instead, Wilcox, ARA’s Chief Financial Officer, and Boucher, ARA’s Chief Accounting Officer, agreed on how much overall revenue they wanted ARA to have every

month or quarter, and then Boucher and Smith, ARA’s Controller, had ARA accounting staff enter different topside adjustments to meet this predetermined number. (Compl. ¶ 10.) The SEC alleges that Defendants engaged in additional deceptive practices, including manipulating which patients’ payment histories were analyzed to make it appear that ARA had more revenue than it did; recognizing the revenue only when needed; manufacturing false and misleading documents to ARA’s external auditors; and misstating or omitting descriptions of topside adjustments in discussions with ARA’s CEO and Audit Committee. (Compl. ¶ 13.) II. Discussion A. Legal Standard Under 28 U.S.C. § 1391(b), venue is proper in a district “in which a substantial part of the events or omissions giving rise to the claim occurred, or a substantial part of that property

that is subject of the action is situated.” Though Defendants concede that venue is proper in the Southern District of New York, they seek a discretionary transfer under 28 U.S.C. § 1404(a). Section 1404(a) provides: “For the convenience of parties and witnesses, in the interest of justice, a district court may transfer any civil action to any other district or division where it might have been brought.” 28 U.S.C. § 1404(a). Section 1404(a) gives district courts broad discretion to decide whether to transfer venue. See In re Cuyahoga Equip. Corp., 980 F.2d 110, 117 (2d Cir. 1992) (“[M]otions for transfer lie within the broad discretion of the district court.”). In deciding a motion to transfer venue under § 1404(a), courts must first inquire “whether the action could have been brought originally in the transferee forum.” Siegel v. Ford, No. 16 Civ. 8077, 2017 WL 4119654, at *7 (S.D.N.Y. Sept. 15, 2017) (quoting Berger v. Cushman &

Wakefield of Penn., Inc., No. 12 Civ. 9224, 2013 WL 456256, at *3 (S.D.N.Y. Aug. 28, 2013)). Here, it is undisputed that the action could have been brought in the District of Massachusetts. (Dkt. No. 25 at 4–5; Dkt. No. 29 at 8.) The second inquiry is “whether transfer would be an appropriate exercise of the Court’s discretion.” Robertson v. Cartinhour, No. 10 Civ. 8442, 2011 WL 5175597, at *3 (S.D.N.Y. Oct. 28, 2011). To determine whether transfer is appropriate, the Court must balance nine factors: “(1) the convenience of the witnesses; (2) the convenience of the parties; (3) the location of relevant documents and the relative ease of access to sources of proof; (4) the locus of operative facts; (5) the availability of process to compel the attendance of unwilling witnesses; (6) the relative means of the parties; (7) the forum’s familiarity with the governing law; (8) the weight accorded the plaintiff’s choice of forum; and (9) trial efficiency and the interests of justice.” SEC v. Hill Int’l, Inc., No. 20 Civ. 447, 2020 WL 2029591, at *3 (S.D.N.Y. Apr. 28, 2020) (internal quotation marks omitted). In evaluating these factors, courts may consider

factual submissions, including declarations by a defendant. Id. B. Analysis 1. Factors Favoring Transfer a. Locus of Operative Facts The locus of operative facts is a “primary factor in determining a § 1404(a) motion to transfer . . . . This factor substantially favors transfer from this district when a party has not shown that any of the operative facts arose in the Southern District of New York.” Hill Int’l, 2020 WL 2029591, at *4 (internal citation and quotation marks omitted). “To determine the locus of operative facts, a court must look to the site of the event from which the claim arises.” AVEMCO Ins. Co. v. GSF Holding Corp., No. 96 Civ. 8323, 1997 WL 566149, at *6 (S.D.N.Y. Sept. 11, 1997) (internal citation and quotation marks omitted).

Here, the central facts giving rise to SEC’s claims occurred in ARA’s headquarters, which was and still is located in Beverly, Massachusetts. The Complaint alleges that Wilcox and Boucher “developed their own system for topside adjustments, and their system was little more than a fraudulent scheme wherein Wilcox, Boucher, and Smith booked millions of dollars in topside adjustments that were not based on patient-level detail, but instead booked to meet predetermined financial metrics.” (Compl. ¶ 77.) The alleged scheme, which was “undertaken on a monthly basis,” involved the following: First, Boucher made initial topside adjustments on his own (Compl. ¶ 78); second, Wilcox and Boucher would determine the “correct” amount of topside revenue to take for ARA (Compl. ¶ 79); and third, Boucher directed Smith and junior personnel acting at her direction to enter topside adjustments equal to what Boucher and Wilcox had determined was the correct amount (Compl. ¶ 80). This alleged scheme, and the conduct behind executing the scheme, all occurred in Massachusetts. Similarly, the Complaint alleges that Defendants misled and made false statements to their Audit Firm, located in Massachusetts.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Royal Insurance Co. of America v. United States
998 F. Supp. 351 (S.D. New York, 1998)
AEC One Stop Group, Inc. v. CD Listening Bar, Inc.
326 F. Supp. 2d 525 (S.D. New York, 2004)
EasyWeb Innovations, LLC v. Facebook, Inc.
888 F. Supp. 2d 342 (E.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Securities and Exchange Commission v. American Renal Associates Holdings, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/securities-and-exchange-commission-v-american-renal-associates-holdings-nysd-2022.